US

Innventure to raise $150 mln maiden venture-capital fund

Innventure has set out to raise a $150 million maiden venture-capital fund, according to a filing with the SEC.

Tot Biopharm attracts $102 mln Series B

Tot Biopharm, a Chinese maker of anti-tumor drugs, has raised $102 million in Series B funding. The investors included China Universal (Cayman) GP Limited, Center Laboratories Group, Vivo Capital, Chengwei Capital, Yuanta Financial Holdings Group and Cathay Capital.

Sierra Ventures leads Series A round for Appcues

Boston-based Appcues, a software company, has secured $10 million in Series A funding, according to a blog post. Sierra Ventures led the round.

SenSat picks up funding

UK-based SenSat, a tech company that simulates reality, has raised 3.31 million pounds in seed funding. The investors included Force Over Mass, Round Hill Venture Partners and Zagm, the venture arm of global creative agency BBH.

Digital health startup Carepoynt inks $2 mln seed

Carepoynt, a digital health startup, has secured $2 million in seed funding. The investors were not named. US Capital Global provided financial advice to Carepoynt on the transaction.

RiverGlade taps Hudak as operating partner

RiverGlade Capital, a healthcare services-focused private equity firm, has named Jim Hudak as an operating partner. Previously, Hudak was CEO of Paradigm Outcomes.

Astellas buys gene therapy company Quethera

Astellas Pharma has acquired UK-based Quethera, a gene therapy company. According to terms of the deal, Astellas may pay up to 85 million pounds to Quethera shareholders. Quethera was backed by UK Innovation and Science Seed Fund and Cambridge Enterprise.

Wonderschool procures $20 mln Series A

San Francisco-based Wonderschool, which provides a platform that helps educators and caregivers start, operate and grow their in-home preschools and daycares, has raised $20 million in Series A financing. Andreessen Horowitz led the round. In conjunction with the funding, Jeff Jordan, a general partner at Andreessen Horowitz, is joining the Wonderschool board.

Artios Pharma nabs $84 mln Series B

UK-based Artios Pharma Limited, a DNA damage response company developing treatments for cancer, has closed $84 million in Series B financing. Andera Partners and LSP led the round with participation from Pfizer Ventures, Novartis Venture Fund, Arix Bioscience, SV Health Investors, M Ventures, IP Group plc and AbbVie Ventures.

Lyvly snags $4.6 mln Series A

UK-based Lyvly, a community platform that helps landlords and renters find and manage shared living accommodation, has raised $4.6 million in Series A funding. The investor was Mosaic Ventures. In addition to the funding, Greg Marsh, the co-founder of onefinestay, will become a chairman of Lyvly and an investor.